StockrabitBrowse analysts
Analyst questions

Ankur Chedda

Firm not listed in source transcripts
ORCHPHARMA

Orchid Pharma Limited

All company calls
Orchid Pharma Limited
21 Aug 2026
Open call
  1. Hello, sorry, yeah. Just one question, is there any risk to the PLI benefit due to the slippage in the timeline, or has that matter been settled with the government?

    Read in transcript
  2. Okay. So, any scope of getting extension on that?

    Read in transcript
  3. Okay. And just one more qu estion on this NPNC business, which came from Dhanuka Laboratories. So, in this quarter, of this 350 revenue, what was the portion of NPNC business?

    Read in transcript
+1 more question in this call